Swisse Ultivite Clinical Trials
The Swisse formulae are based on over 25 years of research and backed by clinical studies, scientific validation or other evidence based on traditional use.
1. The first study was carried out by Swinburne University of Technology: Brain Sciences Institute:
"Effects of Swisse Men's Ultivite on cognition, mood, quality of life and blood measures in a group of older males."
Aim: To investigate the effects of supplementation with Swisse Mens Ultivite on cognition, mood, quality of life and blood measures in a group of older males.
Design: Double blind, randomized, placebo controlled study of 60 male participants, evenly split into control group and study group. Subjects were studied over a period of eight weeks.
Conclusions:
Cognition: Swisse Mens Ultivite improved performance accuracy on a contextual memory task; an effect not present in the placebo group. We have previously shown that performance on this task is susceptible to decline with increasing age. Swisse Mens Ultivite may therefore be effective in countering age related cognitive decline.
Mood: Swisse Mens Ultivite reduced clinical symptoms as measured by the Depression, Anxiety and Stress Scale (DASS). It appears the reductions in the DASS score overall was mainly due to the reduction of depressive symptoms and possibly also due to the reduction of symptoms of stress.
Health-Related Quality of Life: Swisse Mens Ultivite may be effective in improving health-related quality of life: A non-significant trend towards improvement in health-related quality of life, as measured by the General Health Questionnaire (GHQ) was found in the multivitamin group but not in the placebo group.
Blood tests: Swisse Mens Ultivite was effective in reducing homocysteine and increasing blood levels of vitamin B12 and folate:
A statistically significant decrease (-12.5%) in homocysteine was found in the multivitamin group but not in the placebo group.
A statistically significant increase (+26.6%) in vitamin B12 was found in the multivitamin group but not in the placebo group.
A statistically significant increase (+25.5%) in red cell folate was found in the multivitamin group but not in the placebo group.
2. The second study was carried out by Southern Cross University, with the Australian Centre for Complementary Medicine.
"The Effect of a Nutritional Supplement on Premenstrual Syndrome"
Aim: To investigate the effects of supplementation with Swisse Womens Ultivite on Premenstrual Symptoms utilizing the Premenstrual Symptom Score (PMSS) assessed by questionnaire as the primary outcome measure.
Design: Double blind, randomized, placebo controlled trial conducted over 42 weeks using parallel groups of individuals with prospectively confirmed mild to moderate premenstrual tension. The study included 49 subjects randomly allocated into 28 in the active group and 21 in the placebo group.
Psychological symptoms of PMS include depression, anxiety, anger and irritability, rapid mood swings, disinterest in normal activities and lack of concentration; food cravings and fatigue are common complaints while the physical discomforts, bloating, breast tenderness, abdominal pain and headache frequently occur. There were significant reductions in premenstrual syndrome symptoms between the pre-treatment and post treatment stages of the study. The reduction for the active treatment was highly significant and greater than the reduction in symptoms for subjects on placebo. The study showed a 50% improvement for subjects taking the active treatment.